Daniele Pozzessere

Metabolomics to Assess Response to Immune Checkpoint Inhibitors in Patients with Non-Small-Cell Lung Cancer

Veronica Ghini, Letizia Laera, Beatrice Fantechi et al. · Cancers · 2020 · 132 citations · Full text

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Maria Carmela Piccirillo, Laura Bonanno, Marina Chiara Garassino et al. · Journal of Thoracic Oncology · 2022 · 63 citations · Full text

Recruitment of dendritic cells and enhanced antigen-specific immune reactivity in cancer patients treated with hr-GM-CSF (Molgramostim) and hr-IL-2

Pierpaolo Correale, G. Campoccia, K.Y Tsang et al. · European Journal of Cancer · 2001 · 46 citations

Cancer Immunosurveillance, Immunology, Tumor Immunity +10

High-Affinity HLA-A(*)02.01 Peptides from Parathyroid Hormone-Related Protein Generate In Vitro and In Vivo Antitumor CTL Response Without Autoimmune Side Effects

Guido Francini, Antonio Scardino, Kostas Kosmatopoulos et al. · The Journal of Immunology · 2002 · 35 citations · Full text

Tumour-associated antigen (TAA)-specific cytotoxic T cell (CTL) response in vitro and in a mouse model, induced by TAA-plasmids delivered by influenza virosomes

Pierpaolo Correale, Maria Grazia Cusi, Marianna Sabatino et al. · European Journal of Cancer · 2001 · 34 citations

Allergy, Immunology, Immunodominance +9